Chronic fatigue syndrome against the background of the COVID-19 pandemic, 2021, Nikitina & Levin

O

ola_cohn

Established Member (Voting Rights)
Abstract
The more we learn about the new coronavirus infection, the more we understand that we will feel the echoes of the pandemic for many years, and those who have successfully endured the acute phase of COVID-19 may face the consequences of the infection. One of the most frequent manifestations will be the development of chronic fatigue syndrome (CFS) after COVID-19. This article discusses the possible causes of the development of CFS, as well as possible ways of its treatment and prevention.

Keywords: COVID-19; SARS-CoV2; chronic fatigue syndrome; coronavirus; grandaxin; tofizopam.

Open access full text
https://www.mediasphera.ru/issues/z...m-s-s-korsakova/2021/10-2/1199772982021102092
Full article is in Russian, abstract has also been published in English
 
"Grandaxin has a moderate stimulating activity, which is important for patients with CFS."

"In 2021, at the Nizhny Novgorod Regional Clinical Hospital named after V.I. ON THE. Semashko, a study was conducted on the possibility of using daytime anxiolytics to correct residual neurological manifestations of COVID-19. The study involved patients who underwent COVID-19, who, 4 weeks after the end of treatment, had complaints about their underlying disease, suggesting the presence of an anxiety disorder. The Hamilton scale (HAM-A) was used to assess the level of anxiety. Patients were examined before the start of treatment, after 2, 4 and 6 weeks of therapy. Before starting therapy, all patients had a general high level of anxiety: the mean HAM-A score was 31.72 ± 2.24. After the completion of therapy with Grandaxin, all patients showed a decrease in the level of anxiety: the mean HAM-A score was 12.68 ± 2.04. Moreover, normalization of the structure and quality of sleep was noted during treatment with Grandaxin. After the end of the course of therapy, patients noted an increase in mental performance, improved memory and attention. There was a decrease in the severity of anxiety-associated cognitive disorders. Also, as a result of the study, by the end of the 2nd week of therapy with Grandaxin, the severity of somatic muscle disorders decreased by 30% [48].

If we consider the issue of preventing CFS, then it should be noted that positive thoughts and an optimistic attitude, as well as regular moderate physical activity and proper nutrition are currently the only effective way to prevent CFS, including against the background of COVID-19."
 
cfsandmore said:
If we consider the issue of preventing CFS, then it should be noted that positive thoughts and an optimistic attitude, as well as regular moderate physical activity and proper nutrition are currently the only effective way to prevent CFS, including against the background of COVID-19."
Click to expand...

Checklist for my pre-ME days:

- Positive thoughts :thumbup:
- Optimistic attitude :thumbup:
- Proper nutrition :thumbup:
- Regular moderate intense physical activity :emoji_warning:

Oh, OK, now I see how I ruined my whole life.
 
There is no scientifically established way to prevent CFS in part because we do not understand the cause and in part because these claims arise out of unproven hypotheses. Its even worse when you realise these kinds of hypotheses have been found wanting in the science, and that is the polite version.
 
You must log in or register to reply here.
Back
Top Bottom